Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11406561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRCA2 is required for homology-directed repair of chromosomal breaks.

  2001influential reference
• p53 accumulates but is functionally impaired when DNA synthesis is blocked.

  2001cited by this paper
• Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

  2001cited by this paper
• PriA-directed replication fork restart in Escherichia coli.

  2000cited by this paper
• Roles of BRCA1 and its interacting proteins

  2000cited by this paper
• Repair of Intermediate Structures Produced at DNA Interstrand Cross-Links in Saccharomyces cerevisiae

  2000cited by this paper
• Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

  2000cited by this paper
• Identification of a Functional Nuclear Export Sequence in BRCA1*

  2000cited by this paper
• Sister chromatid gene conversion is a prominent double‐strand break repair pathway in mammalian cells

  2000cited by this paper
• DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation

  2000cited by this paper
• Defining the Roles of Nucleotide Excision Repair and Recombination in the Repair of DNA Interstrand Cross-Links in Mammalian Cells

  2000cited by this paper
• Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

  2000cited by this paper
• Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation

  2000cited by this paper
• Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.

  2000cited by this paper
• Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development

  2000cited by this paper
• Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.

  2000cited by this paper
• hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

  2000cited by this paper
• The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin*

  2000influential reference
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells.

  1999cited by this paper
• BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene

  1999cited by this paper
• Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.

  1999cited by this paper
• The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter

  1999cited by this paper
• Brca1 controls homology-directed DNA repair.

  1999influential reference
• Growth Retardation, DNA Repair Defects, and Lack of Spermatogenesis in BRCA1-Deficient Mice

  1999cited by this paper
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999cited by this paper
• The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts.

  1999cited by this paper
• XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

  1999influential reference
• Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

  1999cited by this paper
• Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage*

  1999cited by this paper
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2

  1999cited by this paper
• Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

  1999influential reference
• An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control.

  1998cited by this paper
• Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

  1998cited by this paper
• A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability

  1998cited by this paper
• The murine gene p27Kip1 is haplo-insufficient for tumour suppression

  1998cited by this paper
• XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages.

  1998cited by this paper
• Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations.

  1998cited by this paper
• BRCA1 required for transcription-coupled repair of oxidative DNA damage.

  1998influential reference
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997cited by this paper
• Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination.

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• Loss of heterozygosity induced by a chromosomal double-strand break.

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.

  1997cited by this paper
• Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

  1997cited by this paper
• Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

  1996cited by this paper
• Cross-sensitivity of γ-ray-sensitive hamster mutants to cross-linking agents

  1991cited by this paper
• Genotoxicity of 1-nitronaphthalene in Chinese hamster V79 cells.

  1991cited by this paper
• Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents.

  1991cited by this paper
• Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells

  1990cited by this paper
• Micronucleated spermatids in the seminal fluid of smokers and nonsmokers.

  1986cited by this paper
• Radiation-induced chromosome damage in X-ray-sensitive mutants (xrs) of the Chinese hamster ovary cell line.

  1986cited by this paper

• Mutagenic Potentials of DNA Interstrand Cross-Links Induced by 7,8-Dihydro-8-Oxoadenine

  2026cites this paper
• Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review

  2025cites this paper
• Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution

  2025cites this paper
• Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review

  2025cites this paper
• AmNA‐Modified Antisense Oligonucleotide Targeting MCM8 as a Cancer‐Specific Chemosensitizer for Platinum Compounds

  2025cites this paper
• Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms

  2024cites this paper
• Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer

  2024cites this paper
• BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality

  2024cites this paper
• ELF5: A Molecular Clock for Breast Aging and Cancer Susceptibility

  2024cites this paper
• Integrated pan-cancer analysis and experimental verification of the roles of meiotic nuclear divisions 1 in breast cancer.

  2024cites this paper
• Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review

  2024cites this paper
• Synthetic lethal strategies for the development of cancer therapeutics

  2024cites this paper
• Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells

  2023cites this paper
• DNA repair function scores for 2172 variants in the BRCA1 amino-terminus

  2023cites this paper
• DNA Repair Function Scores for 2172 Variants in the BRCA1 Amino-Terminus

  2023cites this paper
• Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

  2022cites this paper
• TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status

  2022cites this paper
• Inhibitors of ROCK kinases induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells

  2022cites this paper
• BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm

  2022cites this paper
• The BRCA1 isoform, BRCA1-IRIS, operates independently of the full-length BRCA1 in the Fanconi anemia pathway

  2022cites this paper
• Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response

  2022cites this paper
• Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises.

  2021cites this paper
• The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance.

  2021cites this paper
• Single nucleotide polymorphisms in breast cancer susceptibility gene 1 are associated with susceptibility to lung cancer.

  2021cites this paper
• The 1,000 Genomes Project has established the most detailed catalogue of mutations in the human genome, with a frequency of BRCA1 mutations of >1% in the population based on DNA sequence

  2021cites this paper
• RNA m6A methylation regulators in ovarian cancer

  2021cites this paper
• SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation

  2021cites this paper
• Synthetic Lethality in Cancer Therapeutics: The Next Generation.

  2021cites this paper
• BRCA2 Promotes Spontaneous Homologous Recombination In Vivo

  2021cites this paper
• RNA Splicing: Basic Aspects Underlie Antitumor Targeting.

  2020cites this paper
• BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery.

  2020cites this paper
• Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside.

  2020cites this paper
• PARylation During Transcription: Insights into the Fine-Tuning Mechanism and Regulation

  2020cites this paper
• BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis

  2020cites this paper
• The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction.

  2020cites this paper
• Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer

  2020cites this paper
• Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy

  2020cites this paper
• Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy

  2020cites this paper
• Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer

  2020cites this paper
• Recent Advances in DNA Repair Pathway and Its Application in Personalized Care of Metastatic Castration-Resistant Prostate Cancer (mCRPC).

  2020cites this paper
• Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

  2020cites this paper
• C-terminal BRE inhibits cellular proliferation and increases sensitivity to chemotherapeutic drugs of MLL-AF9 acute myeloid leukemia cells

  2019cites this paper
• The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.

  2019cites this paper
• Inhibiting the MCM8‐9 complex selectively sensitizes cancer cells to cisplatin and olaparib

  2019cites this paper
• DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy

  2019cites this paper
• GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes

  2019cites this paper
• BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance

  2019cites this paper
• Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression

  2019cites this paper
• Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells

  2019cites this paper
• Precision Medicine

  2019cites this paper
• Chapter 7 The BRCA 1 and BRCA 2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response , DNA Repair and Cancer Therapy

  2018cites this paper
• Edinburgh Research Explorer The BRCA1-11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

  2018cites this paper
• Pre-clinical Profile and Expectations for Pharmacological ATM Inhibition

  2018cites this paper
• Integrating proteomic and phosphoproteomic data for pathway analysis in breast cancer

  2018cites this paper
• Cancer prevention, the need to preserve the integrity of the genome at all cost

  2018cites this paper
• Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

  2018cites this paper
• BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance

  2018cites this paper
• Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells

  2018cites this paper
• Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

  2018cites this paper
• Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing

  2018influential citation
• Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

  2018cites this paper
• Aberrant RNA Splicing in Cancer and Drug Resistance

  2018cites this paper
• The BARD1 BRCT Domain in Tumor Suppression and Genome Stability

  2018cites this paper
• Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer

  2017cites this paper
• The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer

  2017cites this paper
• Targeting DNA Damage Response Pathways in Cancer

  2017cites this paper
• Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner

  2017cites this paper
• Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis.

  2017cites this paper
• PARP inhibitors: Synthetic lethality in the clinic

  2017cites this paper
• Association between BRCA1 P871L polymorphism and cancer risk: evidence from a meta-analysis

  2017cites this paper
• The BRCA 1 and BRCA 2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response , DNA Repair and Cancer Therapy

  2017cites this paper
• EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation

  2017cites this paper
• UNIVERSITY OF GONDAR COLLEGE OF NATURAL AND COMPUTATIONAL SCIENCES DEPARTMENT OF BIOTECHNOLOGY ASSOCIATION OF ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISMS WITH RISK OF DIABETIC 2 AND ITS COMPLICATION AMONG PATIENTS VISITING

  2017cites this paper
• Síndrome de cáncer de mama y ovario hereditario: Estudio in vitro de variantes BRCA1 y BRCA2 de significado biológico desconocido y búsqueda de nuevos genes responsables de este síndrome

  2016cites this paper
• Identification of molecular targets in vulvar cancers.

  2016cites this paper
• The identification of novel strategies for the prevention and treatment of breast cancer in BRCA1-mutation carriers

  2016cites this paper
• The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

  2016cites this paper
• The effect of the level and timing of folic acid supplementation during the life course on the regulation of breast cancer determining genes, mammary morphology and implications for genome stability and tissue differentiation

  2016cites this paper
• BRCA1 Reflects Myocardial Adverse Remodeling in Idiopathic Dilated Cardiomyopathy.

  2016cites this paper
• Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy.

  2016influential citation
• PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

  2016cites this paper
• Gene Editing 20 Years Later

  2016cites this paper
• Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.

  2016cites this paper
• Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

  2016cites this paper
• FANCJ at the FORK.

  2016cites this paper
• Synthetic lethality: the road to novel therapies for breast cancer.

  2016cites this paper
• A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

  2016cites this paper
• Epigenetic regulation of BRCA1 expression and its role inbreast cancer stem cell development

  2016cites this paper
• Breast Cancer: A Molecular and Redox Snapshot.

  2016cites this paper
• RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance.

  2016cites this paper
• The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.

  2016cites this paper
• Not Restricted to the Ends: Yeast Telomere Proteins Rif1 and Cdc13 Function in Double-Strand Break Repair Pathways with Implications for Genome Stability

  2016cites this paper
• DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma

  2015cites this paper
• Decreased Expression of BRCA2 Accelerates Sporadic Breast Cancer Progression

  2015cites this paper
• Cancer Stem Cells: Biology and Potential Therapeutic Applications

  2015cites this paper
• The BRCA1 and BRCA2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response, DNA Repair and Cancer Therapy

  2015cites this paper